Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Clancy

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Nature|December 7, 2018
Author Correction: Trans-differentiation of outer hair cells into inner hair cells in the absence of INSM1Teerawat Wiwatpanit, Sarah M Lorenzen, Jorge A Cantú, et al.
Science Advances|October 29, 2025
Targeted cell interconversions reveal inner hair cell control of organ of Corti cytoarchitectureIgnacio García-Gómez, Jemma L Webber, Berta Soria-Izquierdo, et al.
Development (Cambridge, England)|May 2, 2023
NHR-23 activity is necessary for C. elegans developmental progression and apical extracellular matrix structure and functionLonden C Johnson, An A Vo, John C Clancy, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Multiscale patterning of a model apical extracellular matrix revealed by systematic endogenous protein taggingJames Matthew Ragle, Murugesan Pooranachithra, Guinevere E Ashley, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residuesSteven M Sparks, Pierette Banker, David M Bickett, et al.
Journal of Medicinal Chemistry|June 14, 2023
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous SolubilityHeeren M Gordhan, Steven T Miller, Daphne C Clancy, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroupsSteven M Sparks, Pierette Banker, David M Bickett, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitorsKaren A Evans, Yue H Li, Frank T Coppo, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacyStephen A Thomson, Pierette Banker, D Mark Bickett, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Nature|December 7, 2018
Author Correction: Trans-differentiation of outer hair cells into inner hair cells in the absence of INSM1Teerawat Wiwatpanit, Sarah M Lorenzen, Jorge A Cantú, et al.
Science Advances|October 29, 2025
Targeted cell interconversions reveal inner hair cell control of organ of Corti cytoarchitectureIgnacio García-Gómez, Jemma L Webber, Berta Soria-Izquierdo, et al.
Development (Cambridge, England)|May 2, 2023
NHR-23 activity is necessary for C. elegans developmental progression and apical extracellular matrix structure and functionLonden C Johnson, An A Vo, John C Clancy, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Multiscale patterning of a model apical extracellular matrix revealed by systematic endogenous protein taggingJames Matthew Ragle, Murugesan Pooranachithra, Guinevere E Ashley, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of Type 2 diabetes: 2. Optimization of serine and threonine ether amino acid residuesSteven M Sparks, Pierette Banker, David M Bickett, et al.
Journal of Medicinal Chemistry|June 14, 2023
Eyes on Topical Ocular Disposition: The Considered Design of a Lead Janus Kinase (JAK) Inhibitor That Utilizes a Unique Azetidin-3-Amino Bridging Scaffold to Attenuate Off-Target Kinase Activity, While Driving Potency and Aqueous SolubilityHeeren M Gordhan, Steven T Miller, Daphne C Clancy, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2008
Anthranilimide-based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes: 1. Identification of 1-amino-1-cycloalkyl carboxylic acid headgroupsSteven M Sparks, Pierette Banker, David M Bickett, et al.
Bioorganic & Medicinal Chemistry Letters|June 17, 2008
Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitorsKaren A Evans, Yue H Li, Frank T Coppo, et al.
Bioorganic & Medicinal Chemistry Letters|January 14, 2009
Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacyStephen A Thomson, Pierette Banker, D Mark Bickett, et al.
Pageof 8